- This event has passed.
VSV-EBOPLUS Annual meeting 2022
September 26, 2022 - September 28, 2022
The VSV-EBOPLUS annual meeting 2022 was held in Camogli (Genova, Italy) on the 26-28 September 2022. The organization will be done by Sclavo Vaccines Association.
It was attended by 36 delegates from 17 institutions. Dr. Yazdan Yazdanpanah, (Université de Paris, IAME, INSERM, Paris, France) and Dr. Gary Kobinger (Galveston National Laboratory, University of Texas, Texas, US) joined the meeting in quality of external guests.
The Annual Meeting 2022 officially started with an opening session chaired by Scientific and Project coordinators. The first session was dedicated to the “rVSV-ZEBOV Ebola vaccine safety and immunogenicity”, also addressing the persistence of antibody responses in rVSV-ZEBOV adult vaccinees. An update on ERVEBO ebola vaccine development was done. The agenda of the meeting was structured including the sessions on “Antibodies characterization in pediatric and adult cohort”, “Data integration and machine learning approaches” and “Transcriptomic analysis”.
Open discussion on VSV-EBOPLUS future manuscripts was organized, in order for Partners involved to discuss on data preparation and have the chance to progress with the preparations of the related papers.
Two keynote speeches were done during the two days of the meeting by Dr. Yazdan Yazdanpanah, (Université de Paris, IAME, INSERM, Paris, France) and by Gary Kobinger (Galveston National Laboratory, University of Texas, Texas, US and CEO of GUARDRx -Global Urgent and Advanced Research and Development, Trois-Rivières, Québec, Canada) titled “Evaluation of safety and immunogenicity of 3 Ebola vaccine strategies in children above 1 and adults (results of Prevac study)” and “The boost-EBOV trial: towards prolonged immune protection” respectively. (Agenda and list of Participants in attachment).